Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SANA
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Sana Biotechnology Inc (SANA) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

SANA Biotechnology trades at $3.85, down 1.79% on the day, with a bullish technical signal from moving averages and a strong analyst consensus of 82% buy ratings. Recent earnings show mixed quarterly results, with two misses and one beat, while financials reflect a pre-revenue biotech with negative net income of -$244.17 million for 2025. Positive sentiment is driven by clinical data presentations and inclusion in genomics stock lists, though cash flow remains negative.
The outlook hinges on clinical progress in engineered cell therapies, with upside potential from successful trials and partnerships. Key risks include high cash burn, lack of profitability, and clinical trial setbacks. Investors should weigh the strong analyst optimism against the company's early-stage financial challenges and biotech sector volatility.
Read full analysis

Key Stats

  • Market Cap
    $1.15B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $5.92
  • 52W Low
    $2.68
  • Typical Hold Time
    -
  • Enterprise Value
    $1.07B
  • Div Yield
    -
  • Trading Activity
    -
$3.84
52W Low: $2.68
12 Jun 2026
52W High: $5.92
15 Oct 2025

Track Sana Biotechnology Inc (SANA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $2.68 and a high of $5.92, highlighting its annual price range. Buy and sell Sana Biotechnology Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Most Recent News

Content is generated by Aura AI

Autoliv advances virtual crash testing with Human Body Model, Toyota first to adopt platform.

Autoliv has developed the Human Body Model (HBM) Safety Suite, a virtual testing platform that simulates detailed human anatomy responses in car crashes. This technology complements physical crash tests by providing deeper insights into injury mechan...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
Autoliv advances virtual crash testing with Human Body Model, Toyota first to adopt platform.

Beta Bionics sued for misleading investors on insulin pump safety and FDA issues, stock price fell.

Schall, Brown & Schwartz LLP filed a class action lawsuit against Beta Bionics for allegedly making false statements about the safety and regulatory status of its iLet Bionic Pancreas insulin pump. The complaint claims Beta Bionics misled investors b...

Market News
5 hours ago
PRNewsWire
Bearish
news icon
Beta Bionics sued for misleading investors on insulin pump safety and FDA issues, stock price fell.

Class action lawsuit alleges Beta Bionics misled investors on FDA safety findings for its insulin pump.

Beta Bionics faces a class action lawsuit for allegedly making false statements about the safety and regulatory status of its iLet Bionic Pancreas insulin pump. The lawsuit claims the company misled investors by downplaying FDA concerns after a facil...

Market News
5 hours ago
PRNewsWire
Bearish
news icon
Class action lawsuit alleges Beta Bionics misled investors on FDA safety findings for its insulin pump.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $1.15B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $5.92
  • 52W Low
    $2.68
  • Typical Hold Time
    -
  • Enterprise Value
    $1.07B
  • Div Yield
    -
  • Trading Activity
    -
$3.84
52W Low: $2.68
12 Jun 2026
52W High: $5.92
15 Oct 2025

Track Sana Biotechnology Inc (SANA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sana Biotechnology Inc has traded between a low of $2.68 and a high of $5.92, highlighting its annual price range. Buy and sell Sana Biotechnology Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!